Pneumonia News

Patients with autoimmune diseases who developed Pneumocystis jirovecii pneumonia were more likely to have taken high doses of glucocorticoids, according to recently published research.

The use of methylprednisolone was related to decreased treatment failure among patients with severe community-acquired pneumonia and a high initial inflammatory response, researchers from Spain have found.

Patients with connective tissue diseases, particularly those who were older, smokers, male and received maximum dosage, treated with prednisolone or other corticosteroids were at higher risk for pulmonary infections, according to researchers from the PREVENT study group.

The use of corticosteroid inhalants was associated with a nearly twofold increased risk for recurrent pneumonia among high-risk pneumonia survivors aged at least 65 years, new findings suggest.

Methicillin-resistant Staphyloccocus aureus was commonly linked to the ventilator-associated pneumonia rate in community hospitals, according to study findings.